ArticleCell communication and signaling : CCS2025
Deubiquitinase MoAMSH inhibits autophagy by targeting MoAtg6 in Magnaporthe oryzae.
Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Ubiquitination is a highly conserved post-translational modification in eukaryotes, and the deubiquitinase associated molecule with the SH3 domain of STAM (AMSH) plays a critical role in reversing this modification, thereby regulating various cellular processes. However, the specific mechanisms by which AMSH influences pathogenicity through autophagy in pathogenic fungi remain poorly understood. In this study, we investigate the multifaceted role of MoAMSH in the development and pathogenicity of Magnaporthe oryzae. We identify MoAMSH and demonstrate that the E346 residue is crucial for its interactions with MoHse1, MoVps24, and MoAtg13. Functional analyses indicate that MoAMSH is essential for growth, conidiation, conidial germination, appressorium formation, and overall pathogenicity. Additionally, MoAMSH plays a significant role in the response to abiotic stress and exhibits K63-linked deubiquitination activity. Our findings further reveal that MoAMSH regulates development and pathogenicity by participating in MAPK pathways. Notably, MoAMSH acts as a negative regulator of autophagy by inhibiting the interaction between MoAtg6 and MoVps34 through the deubiquitination of K63-linked ubiquitinated MoAtg6. In summary, our results uncover a novel regulatory pathway related to autophagy in pathogenic fungi and suggest that AMSH may serve as a potential target for antifungal therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.